Tinnitus group Neuromod raises €30m to fund drive into US market

  • 📰 IrishTimesBiz
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 77%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Irish medtech Neuromod Devices has raised €30 million to fund expansion into the US market after FDA approval of it tinnitus therapy ...and its first target are 2.7 million US army veterans.

“But there is almost twice that with tinnitus – 2.7 million veterans – and they have nothing for them,” Dr O’Neill said. He added that, at present, compensation to this group is costing the US about $4.9 billion a year.

The latest funding – which more than doubles the money the NUI Maynooth spin-out has raised since it was founded in 2010 – is split evenly between venture debt funding from the European Investment Bank and new equity investment. The equity investment was led by a new shareholder, Italian life sciences specialist Panakès, but also includes the company’s existing shareholders.

“We have continued to have the complete support of all of our long-term investors and now Panakès has joined that group as well,” said Dr O’Neill.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 6. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Neuromod raises €30m to fund drive into US marketCompany’s Lenire device approved by FDA uses sound and electric stimulation to ease symptoms of tinnitus
출처: IrishTimesBiz - 🏆 6. / 77 더 많은 것을 읽으십시오 »

Neuromod fundraising, office market slump, proxy adviser backs Kingspan’s MurtaghBusiness Today: the best news, analysis and comment from The Irish Times business desk
출처: IrishTimes - 🏆 3. / 98 더 많은 것을 읽으십시오 »